Fractional Systems and Fractional Bogoliubov Hierarchy Equations

We consider the fractional generalizations of the phase volume, volume element and Poisson brackets. These generalizations lead us to the fractional analog of the phase space. We consider systems on this fractional phase space and fractional analogs of the Hamilton equations. The fractional generalization of the average value is suggested. The fractional analogs of the Bogoliubov hierarchy equations are derived from the fractional Liouville equation. We define the fractional reduced distribution functions. The fractional analog of the Vlasov equation and the Debye radius are considered.Comment: 12 page

The Analysis of Injuries and Mortality Risks Level as a Result of Road Accident in Regions of the Central and Eastern Europe

In the article the analysis of the frequency, traumatism and mortality of road accidents has been carried out at the regional level for the countries of Central and Eastern Europe and has made it possible to draw conclusions regarding certain spatial features of the distribution of these indicators and on the nonrandom nature of the location of their values on maps of the CEE regions featured in the study. On the basis of methods of spatial statistics and econometrics we have demonstrated the existence of a spatial structure in the distribution of the risks and consequences of road accidents in the various regions. Cluster analysis has enabled us to distinguish uniform clusters of regions categorised by the risks, traumatism and mortality rates of road accidents. Based on an analysis of these indicators we have introduced the evaluation of an integrated safety level for regions of the countries of Central and Eastern Europe. This allows us to estimate the complex influence of the risks and their consequences road accidents on the level of safety for certain regions or groups of regions. The results of the research which has been conducted can be used for the improvement of national and regional programs of road and transport safety, and for the development of strategies and actions aimed at reducing the risks and consequences of road accidents in certain regions

Fractional Liouville and BBGKI Equations

We consider the fractional generalizations of Liouville equation. The normalization condition, phase volume, and average values are generalized for fractional case.The interpretation of fractional analog of phase space as a space with fractal dimension and as a space with fractional measure are discussed. The fractional analogs of the Hamiltonian systems are considered as a special class of non-Hamiltonian systems. The fractional generalization of the reduced distribution functions are suggested. The fractional analogs of the BBGKI equations are derived from the fractional Liouville equation.Comment: 20 page

Search for states with enlarged radii in excited states of 12B

An experiment was done to search for states with a neutron halo in 12B. The measurements were carried out at the cyclotron of the University of Jyvaskyla (Finland) using Large Scattering Chamber (LSC). The idea of the work was to search for two states with the expected neutron halo, 1 ̄ and 2 ̄. Differential cross sections with excitation of 12B states, including abovementioned states, were observed. The preliminary calculations on halo radii by the method of asymptotic normalization coefficients for the 2 ̄ and 1 ̄ states which are in a discrete spectrum gave following values: 5.6 fm and 7.4 fm, which is much larger than the radius of the valence neutron in the ground state. But strictly the presence of a neutron halo can be confirmed only for 1 ̄ state. The 2 ̄ state can be considered only as candidate for halo. An unexpected result was obtained for the 3 ̄, 3.39 MeV state, which is in continuum 19 keV above the decay threshold 12B → 11B + n, preliminary estimation for its halo radius is ∼ 6.5 fm. This indicates that the halo can be present in this state as well. But strict conditions for neutron halo are not fulfilled in the same way as for 2 ̄ state. Until now, the neutron halo in unbound states has been observed only for the members of the rotational bands

ANTIBODIES TO BENZO[A]PYRENE IN SERUM OF PATIENTS WITH NON-SMALL CELL LUNG CANCER

The features of immune response to chemical carcinogen benzo[a]pyrene (Bp) at the patients with non-small cell lung cancer (NSCLC) are investigated. The isotypical distinctions in formation of antibodies (Ab) to Bp at the men with NSCLC in comparison with healthy are revealed. There were more often observed the high levels of IgG Ab-Bp at the men with NSCLC. Thus risk of occurrence NSCLC grows almost in 2 times at high levels of Ab-Bp of a class G

The Large Enriched Germanium Experiment for Neutrinoless Double Beta Decay (LEGEND)

The observation of neutrinoless double-beta decay (0${\nu}{\beta}{\beta}$) would show that lepton number is violated, reveal that neutrinos are Majorana particles, and provide information on neutrino mass. A discovery-capable experiment covering the inverted ordering region, with effective Majorana neutrino masses of 15 - 50 meV, will require a tonne-scale experiment with excellent energy resolution and extremely low backgrounds, at the level of $\sim$0.1 count /(FWHM$\cdot$t$\cdot$yr) in the region of the signal. The current generation $^{76}$Ge experiments GERDA and the MAJORANA DEMONSTRATOR utilizing high purity Germanium detectors with an intrinsic energy resolution of 0.12%, have achieved the lowest backgrounds by over an order of magnitude in the 0${\nu}{\beta}{\beta}$ signal region of all 0${\nu}{\beta}{\beta}$ experiments. Building on this success, the LEGEND collaboration has been formed to pursue a tonne-scale $^{76}$Ge experiment. The collaboration aims to develop a phased 0${\nu}{\beta}{\beta}$ experimental program with discovery potential at a half-life approaching or at $10^{28}$ years, using existing resources as appropriate to expedite physics results.Comment: Proceedings of the MEDEX'17 meeting (Prague, May 29 - June 2, 2017

LEGEND-1000 Preconceptual Design Report

We propose the construction of LEGEND-1000, the ton-scale Large Enriched Germanium Experiment for Neutrinoless $\beta \beta$ Decay. This international experiment is designed to answer one of the highest priority questions in fundamental physics. It consists of 1000 kg of Ge detectors enriched to more than 90% in the $^{76}$Ge isotope operated in a liquid argon active shield at a deep underground laboratory. By combining the lowest background levels with the best energy resolution in the field, LEGEND-1000 will perform a quasi-background-free search and can make an unambiguous discovery of neutrinoless double-beta decay with just a handful of counts at the decay $Q$ value. The experiment is designed to probe this decay with a 99.7%-CL discovery sensitivity in the $^{76}$Ge half-life of $1.3\times10^{28}$ years, corresponding to an effective Majorana mass upper limit in the range of 9-21 meV, to cover the inverted-ordering neutrino mass scale with 10 yr of live time

Применение нового нутрицевтика для улучшения переносимости адъювантной химиотерапии

Introduction. Treatment of malignant neoplasms often requires adjuvant chemotherapy (ACT). In real-life clinical practice, a high proportion of patients develop serious toxicities of anticancer therapy. Thus, the need to reduce treatment toxicity while maintaining the same dose levels of chemotherapeutic agents is a pressing challenge in oncology. This article presents the results of the study assessing the effects of the complex nutraceutical Oncoxin on ACT tolerability.Materials and methods. The study included 133 patients aged 50 to 70 years with stage IIB — IIIC gastric cancer or stage IIB — IIIA non-small-cell lung cancer; 84 patients received Oncoxin, and 49 were in the control group.Results. The study revealed that after two weeks, patients receiving Oncocoxin had a twice higher chance of significant (obvious) improvement in their quality of life (ESAS questionnaire) compared to the control group: OR 2.07 [95% CI 1.00-4.29]. By the end of the follow-up period (3 weeks), patients receiving Oncoxin had a significantly higher albumin level compared to the control group (38.1 [95% CI 37.1-39.1] g/L and 35.5 [95% CI 33.9-37.0], р =0.03, respectively). Moreover, the use of Oncoxin allowed significant reducing ACT-related liver toxicity.Conclusions. This study conducted within our current clinical practice showed for the first time a high efficacy of Oncoxin in improving the quality of life of patients and reducing ACT toxicity.Введение. Лечение злокачественных новообразований часто требует применения адъювантной химиотерапии (АХТ). В реальной клинической практике доля пациентов, имеющих серьёзные проявления токсичности противоопухолевого лечения, достаточно высока. Таким образом, необходимость снижения токсичности терапии и сохранение интенсивности дозы химиопрепаратов являются актуальной задачей онкологии. Данная статья посвящена результатам исследования влияния многокомпонентного нутрицевтика Онкоксин на переносимость АХТ.Материалы и методы. В исследование было включено 133 больных раком желудка МВ-ШС или немелкоклеточным раком лёгких ПВ-ША в возрасте 50- 70 лет; 84 получали Онкоксин, 49 составили контрольную группу.Результаты. Было установлено, что через две недели шансы больных, получавших Онкоксин, на значимое (безусловное) улучшение качества жизни (вопросник ESAS) были в два раза выше в сравнении с группой контроля: ОШ = 2,07 [95% ДИ 1,00- 4,29]. К окончанию периода наблюдения (3 недели) в группе пациентов, использовавших Онкоксин, уровень альбумина был значительно выше в сравнении с контрольной группой (38,1 [95% ДИ 37,1- 39,1] г /л и 35,5 [95% ДИ 33,9-37,0], р = 0,03, соответственно). Кроме этого, применение Онкоксина позволило существенно снизить печёночную токсичность АХТ.Выводы. Данное исследование, проведённое в рамках существующей клинической практики, впервые показало высокую эффективность Онкоксина в улучшении качества жизни пациентов и снижении токсичности АХТ